BEZ235 has also shown to exert anti-proliferative activity in Ph− B-ALL cells [95], as well as the PI3K/mTOR inhibitor BTG226, that showed a more powerful effect than BEZ235 [95]. The gene discussed is MTOR; the disease is acute lymphoblastic leukemia.